1. Home
  2. Analysis
  3. Prolia
  4. Cortisone-acetate

Prolia and Cortisone acetate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 77 people who take Prolia and Cortisone acetate. Common interactions include hypoaesthesia among females, and autoimmune disorder among males.

The phase IV clinical study analyzes what interactions people who take Prolia and Cortisone acetate have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 28, 2023

77 people who take Prolia and Cortisone acetate together, and have interactions are studied.

What is Prolia?

Prolia has active ingredients of denosumab. It is used in osteoporosis. Currently, eHealthMe is studying from 145,853 Prolia users.

What is Cortisone acetate?

Cortisone acetate has active ingredients of cortisone acetate. It is used in pain. Currently, eHealthMe is studying from 12,427 Cortisone acetate users.

Number of Prolia and Cortisone acetate reports submitted per year:

Prolia and Cortisone acetate drug interactions.

Common Prolia and Cortisone Acetate drug interactions by gender *:

female:

  1. Hypoaesthesia
  2. Balance disorder
  3. Deafness
  4. Malaise
  5. Paraesthesia
  6. Urinary incontinence
  7. Arthralgia
  8. Amnesia
  9. Dizziness
  10. Faecal incontinence

male:

  1. Autoimmune disorder
  2. Depression
  3. Prostate cancer
  4. Rash erythematous
  5. Sepsis
  6. Sleep disorder
  7. Suture rupture
  8. Venous thrombosis limb
  9. Soft tissue disorder
  10. Leukopenia

Common Prolia and Cortisone Acetate drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Perirectal abscess
  2. Uterine haemorrhage

50-59:

  1. Gait disturbance
  2. Hypoaesthesia
  3. Nasopharyngitis
  4. Pain in extremity
  5. Arthralgia
  6. Connective tissue disorder
  7. Myalgia
  8. Pelvic pain
  9. Bladder cancer
  10. Anxiety

60+:

  1. Fall
  2. Autoimmune disorder
  3. Prostate cancer
  4. Rash erythematous
  5. Sepsis
  6. Sleep disorder
  7. Suture rupture
  8. Venous thrombosis limb
  9. Soft tissue disorder
  10. Leukopenia

Common conditions people have *:

  1. Vasculitis (inflammation of a blood vessel or blood vessels): 39 people, 50.65%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 39 people, 50.65%
  3. Muscle Aches (muscle pain): 39 people, 50.65%
  4. Venous Thrombosis Limb (blood clot that forms in a vein in the limb): 38 people, 49.35%
  5. Temporal Arteritis (inflammation and damage to blood vessels that supply the head area): 14 people, 18.18%
  6. Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 8 people, 10.39%
  7. High Blood Pressure: 5 people, 6.49%
  8. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 4 people, 5.19%
  9. Polymyalgia Rheumatica (pain in many muscles): 4 people, 5.19%

* Approximation only. Some reports may have incomplete information.

Do you take Prolia and Cortisone acetate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Prolia drug interactions:

Browse interactions between Prolia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cortisone acetate drug interactions:

Browse interactions between Cortisone acetate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on denosumab and cortisone acetate (the active ingredients of Prolia and Cortisone acetate, respectively), and Prolia and Cortisone acetate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Prolia and Cortisone acetate.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.